Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic acid for postoperative pulmonary complications in cardiac surgery
NCT03756727Phase 1Unknown
- Sponsor
- Xuzhou Medical University
- Start
- Dec 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ascorbic acid in postoperative pulmonary complications (PPC) (2 arms), sponsored by Xuzhou Medical University. Primary endpoint: Severity of postoperative pulmonary complications at 2 weeks. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT03756727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756727.